• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-HBS2 (AHBS2) ASSAY; AHBS IMMUNOASSAY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-HBS2 (AHBS2) ASSAY; AHBS IMMUNOASSAY, Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/11/2018
Event Type  malfunction  
Manufacturer Narrative
The cause for the (b)(6) advia centaur xp anti-hbs2 (ahbs2) result(s) is being investigated by siemens.
 
Event Description
The customer observed a (b)(6) patient result on a new reagent lot (119096) received.The (b)(6) result was considered to be discordant compared to a (b)(6) repeat result, and the patient's clinical history.The customer has reported observing this issue on other patient samples where (b)(6) results were not confirmed to be (b)(6) based the patient's clinical history, other (b)(6) markers, or repeat (b)(6) alternate (b)(6) test method results.Result information for the other patients has not been provided.The customer stated that no discordant (b)(6) results have been reported to physicians, and the results reported have not been questioned.There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant advia centaur xp (b)(6) result.
 
Manufacturer Narrative
Siemens filed mdr on (b)(6) 2018for a non-reproduced false positive advia centaur xp anti-hbs2 (ahbs2) patient result.01/11/2019 additional information: siemens has completed the incident investigation.Based on the information provided, the cause of the non-reproduced false positive advia centaur xp anti-hbs2 (ahbs2) patient result is unknown, and appears to be a site specific issue.A review of complaints was performed, and there were no other similar complaints found regarding imprecision for reagent lots 119094 and 119096.The advia centaur xp anti-hbs2 reagent lots 119094 and 119096 are performing as intended.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP ANTI-HBS2 (AHBS2) ASSAY
Type of Device
AHBS IMMUNOASSAY,
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key8146843
MDR Text Key130657227
Report Number1219913-2018-00301
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00630414561790
UDI-Public00630414561790
Combination Product (y/n)N
PMA/PMN Number
P100039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/30/2020
Device Model NumberN/A
Device Catalogue Number10286268
Device Lot Number119096
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/22/2018
Initial Date FDA Received12/10/2018
Supplement Dates Manufacturer Received01/11/2019
Supplement Dates FDA Received02/04/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-